Omalizumab in the management of patients with allergic (IgE-mediated) asthma.
about
The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and childrenThe Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children.The differentiation of chronic obstructive pulmonary disease from asthma: a review of current diagnostic and treatment recommendations.Indirect comparison of bronchial thermoplasty versus omalizumab for uncontrolled severe asthma.
P2860
Omalizumab in the management of patients with allergic (IgE-mediated) asthma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Omalizumab in the management of patients with allergic (IgE-mediated) asthma.
@ast
Omalizumab in the management of patients with allergic (IgE-mediated) asthma.
@en
Omalizumab in the management of patients with allergic
@nl
type
label
Omalizumab in the management of patients with allergic (IgE-mediated) asthma.
@ast
Omalizumab in the management of patients with allergic (IgE-mediated) asthma.
@en
Omalizumab in the management of patients with allergic
@nl
prefLabel
Omalizumab in the management of patients with allergic (IgE-mediated) asthma.
@ast
Omalizumab in the management of patients with allergic (IgE-mediated) asthma.
@en
Omalizumab in the management of patients with allergic
@nl
P2860
P356
P1476
Omalizumab in the management of patients with allergic (IgE-mediated) asthma.
@en
P2093
Thomas Sandström
P2860
P356
10.2147/JAA.S3116
P407
P577
2009-05-08T00:00:00Z